Clinical Trial Update: Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating dynamic contrast-enhanced CT to evaluate tumor perfusion in metastatic renal cell carcinoma patients receiving targeted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING